- Report
- January 2022
- 60 Pages
Global
From €3499EUR$3,950USD£3,032GBP
- Report
- January 2022
- 60 Pages
Global
From €3499EUR$3,950USD£3,032GBP
- Report
- January 2022
- 60 Pages
Global
From €3499EUR$3,950USD£3,032GBP
- Report
- January 2022
- 200 Pages
Global
From €6644EUR$7,500USD£5,757GBP
- Report
- January 2022
- 200 Pages
Global
From €6644EUR$7,500USD£5,757GBP
- Report
- January 2022
- 200 Pages
Global
From €6644EUR$7,500USD£5,757GBP
- Report
- January 2022
- 60 Pages
Global
From €3499EUR$3,950USD£3,032GBP
- Report
- January 2022
- 60 Pages
Global
From €3499EUR$3,950USD£3,032GBP
- Drug Pipelines
- January 2022
- 100 Pages
Global
From €5049EUR$5,700USD£4,375GBP
- Report
- January 2022
- 60 Pages
Global
From €3499EUR$3,950USD£3,032GBP
- Report
- January 2022
- 60 Pages
Global
From €3499EUR$3,950USD£3,032GBP
- Report
- December 2024
- 70 Pages
India
From €2635EUR$2,975USD£2,283GBP
€3100EUR$3,500USD£2,686GBP
- Report
- August 2024
- 82 Pages
Japan
From €2635EUR$2,975USD£2,283GBP
€3100EUR$3,500USD£2,686GBP
- Report
- August 2024
- 82 Pages
Japan
From €2635EUR$2,975USD£2,283GBP
€3100EUR$3,500USD£2,686GBP
- Report
- June 2024
- 185 Pages
Global
From €3388EUR$3,825USD£2,936GBP
€3986EUR$4,500USD£3,454GBP
- Report
- February 2024
- 182 Pages
Global
From €3388EUR$3,825USD£2,936GBP
€3986EUR$4,500USD£3,454GBP
- Report
- February 2024
- 176 Pages
Global
From €3388EUR$3,825USD£2,936GBP
€3986EUR$4,500USD£3,454GBP
- Report
- February 2024
- 181 Pages
Global
From €3388EUR$3,825USD£2,936GBP
€3986EUR$4,500USD£3,454GBP
- Report
- October 2023
- 90 Pages
United States
From €2635EUR$2,975USD£2,283GBP
€3100EUR$3,500USD£2,686GBP
- Report
- October 2023
- 71 Pages
India
From €2635EUR$2,975USD£2,283GBP
€3100EUR$3,500USD£2,686GBP

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more